Randomized double-blind trial finds uncertain clinical symptom improvement from oral montelukast in acute asthma exacerbations, highlighting unresolved efficacy.
Montelukast is a leukotriene receptor antagonist that helps treat chronic asthma and allergic rhinitis by reducing inflammation and bronchoconstriction. However, oral montelukast's effectiveness in managing acute asthma attacks has yet to be completely identified.
No takes yet. Share an insight, caveat, or question.
Aliyali et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: